Our work in TB
The Union works towards the global elimination of TB. We support high-quality, accessible prevention and care for people with and at risk of TB, to expand the evidence base for TB care and prevention and implement new knowledge into policy and practice.
Specific TB priority areas
Read more about how The Union is working to fight key areas of TB:
The Union works to develop, test, implement and scale up routine screening of child contacts of people with TB. We run observational studies and advocate to ensure children and adolescents are included in clinical trials that target diagnostics, vaccines and treatment of TB disease and infection.
The Union develops, tests, implements and scales up models of care for co-morbid conditions that increase the risk of developing TB, that are prevalent in high TB burden settings, or that adversely affect TB treatment outcomes.
The Zoonotic TB Sub-section was instrumental in the creation of the first-ever Roadmap for Zoonotic TB, a policy document that addressed the major health and economic impacts of the disease, created in collaboration with the World Health Organization.
Members work together to influence global policy and practice, ensuring their work has a greater global impact.
Tuberculosis Union news
On 18th July 2021, we celebrate the 100th anniversary of the first use of the BCG vaccine for TB. An Editorial in IJTLD discusses BCG’s efficacy, heterologous protection and controversial link with COVID-19. The preprint is free to read.
An Editorial for IJTLD highlights the importance of TB preventive treatment (TPT) and the launch by WHO, governments, civil society and other partners of a ‘Call to Action’ for broader access to TPT for those in need. The article is free to read.
In this Correspondence accepted article for IJTLD, the authors found a 67.4% decrease in testing, a 66.9% decrease in bacteriologically confirmed (bac+) diagnosis and a 58.9% decrease in diagnosis of all forms TB. The preprint is free to read.
Until recently, the focus has been on finding and treating people with TB. But now bold targets for TB prevention have been outlined in the recent UN High-Level Meeting on TB. The Union develops, tests, implements and scales up models of care to increase the uptake and completion of TB preventive treatments in key high risk groups including children under 5 and people living with HIV.
'Prevent Tuberculosis: Management of TB Infection' is a free course which improves knowledge of all aspects of the management of TB infection including the diagnosis and treatment of tuberculosis with the specific aim of increasing country-level implementation of TB prevention among i) household contact of people affected by TB, especially those under five years of age, ii) persons with risk factors to develop TB, and iii) people living with HIV in care.